Medical Care

Global Acne Vulgaris Treatment Market Research Report 2025

The global market for Acne Vulgaris Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Acne Vulgaris Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acne Vulgaris Treatment.
The Acne Vulgaris Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acne Vulgaris Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acne Vulgaris Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Segment by Type
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acne Vulgaris Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CB-0601
1.2.3 CJM-112
1.2.4 CLS-007
1.2.5 Dapsone
1.2.6 DFD-10
1.2.7 DLX-2323
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acne Vulgaris Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acne Vulgaris Treatment Market Perspective (2020-2031)
2.2 Global Acne Vulgaris Treatment Growth Trends by Region
2.2.1 Global Acne Vulgaris Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Acne Vulgaris Treatment Historic Market Size by Region (2020-2025)
2.2.3 Acne Vulgaris Treatment Forecasted Market Size by Region (2026-2031)
2.3 Acne Vulgaris Treatment Market Dynamics
2.3.1 Acne Vulgaris Treatment Industry Trends
2.3.2 Acne Vulgaris Treatment Market Drivers
2.3.3 Acne Vulgaris Treatment Market Challenges
2.3.4 Acne Vulgaris Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acne Vulgaris Treatment Players by Revenue
3.1.1 Global Top Acne Vulgaris Treatment Players by Revenue (2020-2025)
3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Acne Vulgaris Treatment Revenue
3.4 Global Acne Vulgaris Treatment Market Concentration Ratio
3.4.1 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Treatment Revenue in 2024
3.5 Global Key Players of Acne Vulgaris Treatment Head office and Area Served
3.6 Global Key Players of Acne Vulgaris Treatment, Product and Application
3.7 Global Key Players of Acne Vulgaris Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Acne Vulgaris Treatment Breakdown Data by Type
4.1 Global Acne Vulgaris Treatment Historic Market Size by Type (2020-2025)
4.2 Global Acne Vulgaris Treatment Forecasted Market Size by Type (2026-2031)
5 Acne Vulgaris Treatment Breakdown Data by Application
5.1 Global Acne Vulgaris Treatment Historic Market Size by Application (2020-2025)
5.2 Global Acne Vulgaris Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Acne Vulgaris Treatment Market Size (2020-2031)
6.2 North America Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Acne Vulgaris Treatment Market Size by Country (2020-2025)
6.4 North America Acne Vulgaris Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acne Vulgaris Treatment Market Size (2020-2031)
7.2 Europe Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Acne Vulgaris Treatment Market Size by Country (2020-2025)
7.4 Europe Acne Vulgaris Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acne Vulgaris Treatment Market Size (2020-2031)
8.2 Asia-Pacific Acne Vulgaris Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acne Vulgaris Treatment Market Size (2020-2031)
9.2 Latin America Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Acne Vulgaris Treatment Market Size by Country (2020-2025)
9.4 Latin America Acne Vulgaris Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acne Vulgaris Treatment Market Size (2020-2031)
10.2 Middle East & Africa Acne Vulgaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Common Pharma Inc
11.1.1 Common Pharma Inc Company Details
11.1.2 Common Pharma Inc Business Overview
11.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
11.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.1.5 Common Pharma Inc Recent Development
11.2 Cutanea Life Sciences Inc
11.2.1 Cutanea Life Sciences Inc Company Details
11.2.2 Cutanea Life Sciences Inc Business Overview
11.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
11.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.2.5 Cutanea Life Sciences Inc Recent Development
11.3 Dermira Inc
11.3.1 Dermira Inc Company Details
11.3.2 Dermira Inc Business Overview
11.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
11.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.3.5 Dermira Inc Recent Development
11.4 ELORAC Inc
11.4.1 ELORAC Inc Company Details
11.4.2 ELORAC Inc Business Overview
11.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
11.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.4.5 ELORAC Inc Recent Development
11.5 Ensol Biosciences Inc
11.5.1 Ensol Biosciences Inc Company Details
11.5.2 Ensol Biosciences Inc Business Overview
11.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
11.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.5.5 Ensol Biosciences Inc Recent Development
11.6 Foamix Pharmaceuticals Ltd
11.6.1 Foamix Pharmaceuticals Ltd Company Details
11.6.2 Foamix Pharmaceuticals Ltd Business Overview
11.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
11.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.6.5 Foamix Pharmaceuticals Ltd Recent Development
11.7 Galderma SA
11.7.1 Galderma SA Company Details
11.7.2 Galderma SA Business Overview
11.7.3 Galderma SA Acne Vulgaris Treatment Introduction
11.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.7.5 Galderma SA Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Details
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Helix BioMedix Inc
11.9.1 Helix BioMedix Inc Company Details
11.9.2 Helix BioMedix Inc Business Overview
11.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
11.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.9.5 Helix BioMedix Inc Recent Development
11.10 Hovione FarmaCiencia SA
11.10.1 Hovione FarmaCiencia SA Company Details
11.10.2 Hovione FarmaCiencia SA Business Overview
11.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
11.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.10.5 Hovione FarmaCiencia SA Recent Development
11.11 Lee's Pharmaceutical Holdings Ltd
11.11.1 Lee's Pharmaceutical Holdings Ltd Company Details
11.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview
11.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
11.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
11.12 LEO Pharma A/S
11.12.1 LEO Pharma A/S Company Details
11.12.2 LEO Pharma A/S Business Overview
11.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
11.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.12.5 LEO Pharma A/S Recent Development
11.13 Novabiotics Ltd
11.13.1 Novabiotics Ltd Company Details
11.13.2 Novabiotics Ltd Business Overview
11.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
11.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.13.5 Novabiotics Ltd Recent Development
11.14 Novan Inc
11.14.1 Novan Inc Company Details
11.14.2 Novan Inc Business Overview
11.14.3 Novan Inc Acne Vulgaris Treatment Introduction
11.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.14.5 Novan Inc Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Acne Vulgaris Treatment Introduction
11.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.15.5 Novartis AG Recent Development
11.16 Paratek Pharmaceuticals Inc
11.16.1 Paratek Pharmaceuticals Inc Company Details
11.16.2 Paratek Pharmaceuticals Inc Business Overview
11.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
11.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.16.5 Paratek Pharmaceuticals Inc Recent Development
11.17 Pfizer Inc
11.17.1 Pfizer Inc Company Details
11.17.2 Pfizer Inc Business Overview
11.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
11.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.17.5 Pfizer Inc Recent Development
11.18 Phosphagenics Ltd
11.18.1 Phosphagenics Ltd Company Details
11.18.2 Phosphagenics Ltd Business Overview
11.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
11.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025)
11.18.5 Phosphagenics Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Acne Vulgaris Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CB-0601
Table 3. Key Players of CJM-112
Table 4. Key Players of CLS-007
Table 5. Key Players of Dapsone
Table 6. Key Players of DFD-10
Table 7. Key Players of DLX-2323
Table 8. Key Players of Others
Table 9. Global Acne Vulgaris Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Acne Vulgaris Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Acne Vulgaris Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Acne Vulgaris Treatment Market Share by Region (2020-2025)
Table 13. Global Acne Vulgaris Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Acne Vulgaris Treatment Market Share by Region (2026-2031)
Table 15. Acne Vulgaris Treatment Market Trends
Table 16. Acne Vulgaris Treatment Market Drivers
Table 17. Acne Vulgaris Treatment Market Challenges
Table 18. Acne Vulgaris Treatment Market Restraints
Table 19. Global Acne Vulgaris Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Acne Vulgaris Treatment Market Share by Players (2020-2025)
Table 21. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2024)
Table 22. Ranking of Global Top Acne Vulgaris Treatment Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Acne Vulgaris Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Acne Vulgaris Treatment, Headquarters and Area Served
Table 25. Global Key Players of Acne Vulgaris Treatment, Product and Application
Table 26. Global Key Players of Acne Vulgaris Treatment, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acne Vulgaris Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Acne Vulgaris Treatment Revenue Market Share by Type (2020-2025)
Table 30. Global Acne Vulgaris Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Acne Vulgaris Treatment Revenue Market Share by Type (2026-2031)
Table 32. Global Acne Vulgaris Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Acne Vulgaris Treatment Revenue Market Share by Application (2020-2025)
Table 34. Global Acne Vulgaris Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Acne Vulgaris Treatment Revenue Market Share by Application (2026-2031)
Table 36. North America Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Acne Vulgaris Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Acne Vulgaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 51. Common Pharma Inc Company Details
Table 52. Common Pharma Inc Business Overview
Table 53. Common Pharma Inc Acne Vulgaris Treatment Product
Table 54. Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 55. Common Pharma Inc Recent Development
Table 56. Cutanea Life Sciences Inc Company Details
Table 57. Cutanea Life Sciences Inc Business Overview
Table 58. Cutanea Life Sciences Inc Acne Vulgaris Treatment Product
Table 59. Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 60. Cutanea Life Sciences Inc Recent Development
Table 61. Dermira Inc Company Details
Table 62. Dermira Inc Business Overview
Table 63. Dermira Inc Acne Vulgaris Treatment Product
Table 64. Dermira Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 65. Dermira Inc Recent Development
Table 66. ELORAC Inc Company Details
Table 67. ELORAC Inc Business Overview
Table 68. ELORAC Inc Acne Vulgaris Treatment Product
Table 69. ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 70. ELORAC Inc Recent Development
Table 71. Ensol Biosciences Inc Company Details
Table 72. Ensol Biosciences Inc Business Overview
Table 73. Ensol Biosciences Inc Acne Vulgaris Treatment Product
Table 74. Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 75. Ensol Biosciences Inc Recent Development
Table 76. Foamix Pharmaceuticals Ltd Company Details
Table 77. Foamix Pharmaceuticals Ltd Business Overview
Table 78. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product
Table 79. Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 80. Foamix Pharmaceuticals Ltd Recent Development
Table 81. Galderma SA Company Details
Table 82. Galderma SA Business Overview
Table 83. Galderma SA Acne Vulgaris Treatment Product
Table 84. Galderma SA Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 85. Galderma SA Recent Development
Table 86. GlaxoSmithKline Plc Company Details
Table 87. GlaxoSmithKline Plc Business Overview
Table 88. GlaxoSmithKline Plc Acne Vulgaris Treatment Product
Table 89. GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 90. GlaxoSmithKline Plc Recent Development
Table 91. Helix BioMedix Inc Company Details
Table 92. Helix BioMedix Inc Business Overview
Table 93. Helix BioMedix Inc Acne Vulgaris Treatment Product
Table 94. Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 95. Helix BioMedix Inc Recent Development
Table 96. Hovione FarmaCiencia SA Company Details
Table 97. Hovione FarmaCiencia SA Business Overview
Table 98. Hovione FarmaCiencia SA Acne Vulgaris Treatment Product
Table 99. Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 100. Hovione FarmaCiencia SA Recent Development
Table 101. Lee's Pharmaceutical Holdings Ltd Company Details
Table 102. Lee's Pharmaceutical Holdings Ltd Business Overview
Table 103. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product
Table 104. Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 105. Lee's Pharmaceutical Holdings Ltd Recent Development
Table 106. LEO Pharma A/S Company Details
Table 107. LEO Pharma A/S Business Overview
Table 108. LEO Pharma A/S Acne Vulgaris Treatment Product
Table 109. LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 110. LEO Pharma A/S Recent Development
Table 111. Novabiotics Ltd Company Details
Table 112. Novabiotics Ltd Business Overview
Table 113. Novabiotics Ltd Acne Vulgaris Treatment Product
Table 114. Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 115. Novabiotics Ltd Recent Development
Table 116. Novan Inc Company Details
Table 117. Novan Inc Business Overview
Table 118. Novan Inc Acne Vulgaris Treatment Product
Table 119. Novan Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 120. Novan Inc Recent Development
Table 121. Novartis AG Company Details
Table 122. Novartis AG Business Overview
Table 123. Novartis AG Acne Vulgaris Treatment Product
Table 124. Novartis AG Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 125. Novartis AG Recent Development
Table 126. Paratek Pharmaceuticals Inc Company Details
Table 127. Paratek Pharmaceuticals Inc Business Overview
Table 128. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product
Table 129. Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 130. Paratek Pharmaceuticals Inc Recent Development
Table 131. Pfizer Inc Company Details
Table 132. Pfizer Inc Business Overview
Table 133. Pfizer Inc Acne Vulgaris Treatment Product
Table 134. Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 135. Pfizer Inc Recent Development
Table 136. Phosphagenics Ltd Company Details
Table 137. Phosphagenics Ltd Business Overview
Table 138. Phosphagenics Ltd Acne Vulgaris Treatment Product
Table 139. Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2020-2025) & (US$ Million)
Table 140. Phosphagenics Ltd Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report


List of Figures
Figure 1. Acne Vulgaris Treatment Picture
Figure 2. Global Acne Vulgaris Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Acne Vulgaris Treatment Market Share by Type: 2024 VS 2031
Figure 4. CB-0601 Features
Figure 5. CJM-112 Features
Figure 6. CLS-007 Features
Figure 7. Dapsone Features
Figure 8. DFD-10 Features
Figure 9. DLX-2323 Features
Figure 10. Others Features
Figure 11. Global Acne Vulgaris Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Acne Vulgaris Treatment Market Share by Application: 2024 VS 2031
Figure 13. Clinic Case Studies
Figure 14. Hospital Case Studies
Figure 15. Others Case Studies
Figure 16. Acne Vulgaris Treatment Report Years Considered
Figure 17. Global Acne Vulgaris Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Acne Vulgaris Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Acne Vulgaris Treatment Market Share by Region: 2024 VS 2031
Figure 20. Global Acne Vulgaris Treatment Market Share by Players in 2024
Figure 21. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Acne Vulgaris Treatment Revenue in 2024
Figure 23. North America Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Acne Vulgaris Treatment Market Share by Country (2020-2031)
Figure 25. United States Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Acne Vulgaris Treatment Market Share by Country (2020-2031)
Figure 29. Germany Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Acne Vulgaris Treatment Market Share by Region (2020-2031)
Figure 37. China Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Acne Vulgaris Treatment Market Share by Country (2020-2031)
Figure 45. Mexico Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Acne Vulgaris Treatment Market Share by Country (2020-2031)
Figure 49. Turkey Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Acne Vulgaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Common Pharma Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 53. Cutanea Life Sciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 54. Dermira Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 55. ELORAC Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 56. Ensol Biosciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 57. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 58. Galderma SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 60. Helix BioMedix Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 61. Hovione FarmaCiencia SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 62. Lee's Pharmaceutical Holdings Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 63. LEO Pharma A/S Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 64. Novabiotics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 65. Novan Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 66. Novartis AG Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 67. Paratek Pharmaceuticals Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 68. Pfizer Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 69. Phosphagenics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies